Leptin levels are associated with multiple sclerosis risk. 2021

Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.

Obesity early in life has been linked to increased risk of developing multiple sclerosis (MS). Leptin and insulin are both associated with obesity, making them suitable candidates for investigating this connection. To determine if leptin and insulin are risk factors for relapsing-remitting multiple sclerosis (RRMS). In this nested case-control study using blood samples from Swedish biobanks, we compared concentrations of leptin and insulin in 649 individuals who later developed RRMS with 649 controls matched for biobank, sex, age and date of sampling. Only pre-symptomatically drawn samples from individuals below the age of 40 years were included. Conditional logistic regression was performed on z-scored values to calculate odds ratios (ORs) with 95% confidence intervals (CIs). A 1-unit leptin z-score increase was associated with increased risk of MS in individuals younger than 20 years (OR = 1.4, 95% CI = 1.1-1.9) and in all men (OR = 1.4, 95% CI = 1.0-2.0). In contrast, for women aged 30-39 years, there was a lower risk of MS with increased leptin levels (OR = 0.74, 95% CI = 0.54-1.0) when adjusting for insulin levels. We show that the pro-inflammatory adipokine leptin is a risk factor for MS among young individuals.

UI MeSH Term Description Entries
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016015 Logistic Models Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor. Logistic Regression,Logit Models,Models, Logistic,Logistic Model,Logistic Regressions,Logit Model,Model, Logistic,Model, Logit,Models, Logit,Regression, Logistic,Regressions, Logistic
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D020529 Multiple Sclerosis, Relapsing-Remitting The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914) Multiple Sclerosis, Acute Relapsing,Relapsing-Remitting Multiple Sclerosis,Acute Relapsing Multiple Sclerosis,Remitting-Relapsing Multiple Sclerosis,Multiple Sclerosis, Relapsing Remitting,Multiple Sclerosis, Remitting-Relapsing,Relapsing Remitting Multiple Sclerosis,Remitting Relapsing Multiple Sclerosis
D020738 Leptin A 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage. Ob Protein,Obese Protein,Ob Gene Product,Obese Gene Product,Gene Product, Ob,Gene Product, Obese

Related Publications

Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
November 2019, Multiple sclerosis and related disorders,
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
June 2020, Neurology,
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
October 2018, Journal of neuroimmunology,
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
January 2003, Cerebrovascular diseases (Basel, Switzerland),
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
July 2012, Neurology,
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
May 2016, Immunological investigations,
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
January 2018, Muscle & nerve,
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
November 2019, Multiple sclerosis and related disorders,
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
August 2009, Multiple sclerosis (Houndmills, Basingstoke, England),
Martin Biström, and Johan Hultdin, and Oluf Andersen, and Lucia Alonso-Magdalena, and Daniel Jons, and Martin Gunnarsson, and Magnus Vrethem, and Peter Sundström
April 2017, Cephalalgia : an international journal of headache,
Copied contents to your clipboard!